Related Experiment Video
Updated: Nov 27, 2025
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
14.8K
Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience.
Massimo Iafrate1, Giovanni Motterle1, Carlotta Zaborra1
1Urology Clinic Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.
Frontiers in Surgery
|December 7, 2020
Summary
Spermatic cord sarcomas have a good 5-year survival rate of 91.3%. Achieving negative surgical margins through wide radical resection is crucial for improving outcomes in these rare genitourinary cancers.
Area of Science:
- Genitourinary oncology
- Surgical pathology
Background:
- Spermatic cord sarcomas are rare genitourinary malignancies with poorly defined prognostic factors.
- Limited data exists regarding optimal diagnostic and therapeutic strategies.
Purpose of the Study:
- To evaluate clinicopathological characteristics and survival outcomes of spermatic cord sarcoma patients.
- To identify prognostic factors influencing disease-specific survival.
Main Methods:
- Retrospective chart review of 22 adult patients over 20 years.
- Analysis of clinicopathological data, treatment, and survival outcomes.
- Statistical analysis to identify prognostic factors.
Main Results:
- Median age at diagnosis was 68 years; liposarcoma was the most common histotype (14/22).
- 63.6% of patients had positive surgical margins.
- 5-year cancer-specific survival was 91.3%; grading, histotype, and intervention type were not significant prognostic factors.
Conclusions:
- Spermatic cord sarcoma demonstrates a favorable 5-year prognosis.
- Wide radical resection aiming for negative surgical margins is the primary treatment strategy.
